Add to ORKGBACKGROUND The vast majority of clinical trials regarding bioresorbable vascular scaffold (BVS) use came from comparison of everolimus-eluting scaffolds with metallic stents, and it remains unclearwhether similar results would be true when a different type of BVS isused. This study sought to evaluate the long-term performance ofnovolimus-eluting bioresorbable vascular scaffolds (nBVSs) comparedwith everolimus-eluting bioresorbable vascular scaffolds (eBVS).METHODS A total of 140 patients with nBVS (n ¼ 202 before exclusion) and 98 patients with eBVS (n ¼ 135 before exclusion) wereincluded in current study. After propensity-score matching, 98 patients treated with 135 eBVSs were compared with 98 patients treatedwith 136 nBVSs. The primary ou...
BACKGROUND No medium-term data are available on the random comparison between everolimus-eluting ...
Background No medium-term data are available on the random comparison between everolimus-eluting bio...
No medium-term data are available on the random comparison between everolimus-eluting bioresorbable ...
BACKGROUND: Most of the current data regarding the use of bioresorbable scaffolds (BRS) come from ev...
Background The Absorb bioresorbable vascular scaffold (BVS) was developed to address long-term safet...
Background: The Absorb bioresorbable vascular scaffold (BVS) was developed to address long-term safe...
Background: Absorb bioresorbable vascular scaffold (BVS)-related events have been reported between 1...
Background: Absorb bioresorbable vascular scaffold (BVS)-related events have been reported between 1...
Background: Absorb bioresorbable vascular scaffold (BVS)-related events have been reported between 1...
AbstractBackgroundThe Absorb bioresorbable vascular scaffold (BVS) was developed to address long-ter...
BACKGROUND: Second-generation everolimus-eluting stents (EES) and third generation biolimus-eluting...
to compare the 1-year outcome between bioresorbable vascular scaffold (BVS), everolimus-eluting sten...
Aims Theoretically, bioresorbable vascular scaffolds (BVSs) may provide superior long-term results c...
to compare the 1-year outcome between bioresorbable vascular scaffold (BVS), everolimus-eluting sten...
Background: Data on procedural and clinical outcomes of the everolimus-eluting bioresorbable vascula...
BACKGROUND No medium-term data are available on the random comparison between everolimus-eluting ...
Background No medium-term data are available on the random comparison between everolimus-eluting bio...
No medium-term data are available on the random comparison between everolimus-eluting bioresorbable ...
BACKGROUND: Most of the current data regarding the use of bioresorbable scaffolds (BRS) come from ev...
Background The Absorb bioresorbable vascular scaffold (BVS) was developed to address long-term safet...
Background: The Absorb bioresorbable vascular scaffold (BVS) was developed to address long-term safe...
Background: Absorb bioresorbable vascular scaffold (BVS)-related events have been reported between 1...
Background: Absorb bioresorbable vascular scaffold (BVS)-related events have been reported between 1...
Background: Absorb bioresorbable vascular scaffold (BVS)-related events have been reported between 1...
AbstractBackgroundThe Absorb bioresorbable vascular scaffold (BVS) was developed to address long-ter...
BACKGROUND: Second-generation everolimus-eluting stents (EES) and third generation biolimus-eluting...
to compare the 1-year outcome between bioresorbable vascular scaffold (BVS), everolimus-eluting sten...
Aims Theoretically, bioresorbable vascular scaffolds (BVSs) may provide superior long-term results c...
to compare the 1-year outcome between bioresorbable vascular scaffold (BVS), everolimus-eluting sten...
Background: Data on procedural and clinical outcomes of the everolimus-eluting bioresorbable vascula...
BACKGROUND No medium-term data are available on the random comparison between everolimus-eluting ...
Background No medium-term data are available on the random comparison between everolimus-eluting bio...
No medium-term data are available on the random comparison between everolimus-eluting bioresorbable ...